Efficacy and safety of nivolumab monotherapy for advanced esophageal squamous cell carcinoma: A retrospective study
Latest Information Update: 07 Mar 2022
At a glance
- Drugs Nivolumab (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Jan 2022 Results presented at the 2022 Gastrointestinal Cancers Symposium
- 23 Feb 2021 New trial record
- 17 Jan 2021 Results presented at the 2021 Gastrointestinal Cancers Symposium